Weil Gotshal & Manges and Linklaters are advising a share tender of Scandinavian biotech firm Swedish Orphan Biovitrum (Sobi) for €6.8 billion.

Weil Gotshal is advising U.S. private equity giant Advent International in cooperation with Finnish firm Roschier Advokatbyrå AB, while Linklaters is advising Singaporean wealth fund GIC through its investment vehicle Aurora Investment.